Transcarent to acquire Accolade
Share!
coverager - Jan 10, 2025
Transcarent will acquire Accolade for $7.03 per share in cash, which represents a total equity value of approximately $621M....
Recommended Articles
CriticalIllness.com appears inactive after 2022 launch
Posted: May 12, 2025
An Assurity initiative....
Willis launches FinTech Plus
Posted: May 12, 2025
The coverage is designed for fintechs based all over the world....
Dai-ichi Life to increase stake in UK hedge fund Capula
Posted: May 12, 2025
Capula is an alternative asset management company established in 2005....